MSI-H 实体恶性肿瘤的临床试验
总计6937个结果
-
Peregrine Pharmaceuticals终止
-
Mabwell (Shanghai) Bioscience Co., Ltd.尚未招聘
-
Sir Run Run Shaw HospitalHangzhou Neoantigen Therapeutics Co., Ltd.主动,不招人
-
Syndax Pharmaceuticals完全的
-
Zai Lab (Hong Kong), Ltd.Merck Sharp & Dohme LLC; Zai Biopharmaceutical (Shanghai) Co., Ltd.招聘中
-
Center Eugene MarquisLigue contre le cancer, France招聘中
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.Jiangsu Aosaikang Biomedicine Co. LTD.招聘中
-
ImmuneOncia Therapeutics Inc.尚未招聘TMB-H | 组织学或细胞学证明的转移性或局部晚期实体瘤
-
SynCore Biotechnology Co., Ltd.不再可用
-
Sir Run Run Shaw HospitalHangzhou Neoantigen Therapeutics Co., Ltd.招聘中
-
The First Affiliated Hospital of Guangzhou Medical...Sinotau Pharmaceutical Group完全的
-
National Cancer Institute (NCI)完全的晚期恶性实体瘤 | 难治性恶性实体瘤 | 复发性恶性实体瘤 | 转移性恶性实体瘤 | 卵巢癌 | 胰腺神经内分泌肿瘤 | 不可切除的实体瘤 | 纤维板层癌美国
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin Health完全的
-
The Sixth Affiliated Hospital of Wenzhou Medical...Zhejiang Qixin Biotech未知
-
Jules Bordet Institute招聘中黑色素瘤 | 肾细胞癌 | 乳腺癌 | 头颈癌 | 小细胞肺癌 | 肝细胞癌 | 非小细胞肺癌 | 间皮瘤,恶性 | 膀胱癌 | 胃肠癌 | 默克尔细胞癌 | 非黑色素瘤皮肤癌 | MSI-H 结直肠癌比利时
-
Chinese PLA General HospitalSinotau Pharmaceutical Group完全的
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering Institute完全的
-
Boehringer Ingelheim完全的
-
The Netherlands Cancer InstitutePfizer未知
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人